What Is HPLC and How Does It Test Peptide Purity?

What is HPLC?

HPLC stands for high-performance liquid chromatography, an analytical separation technique used to determine what is in a sample and in what proportion. A liquid sample is pushed by a high-pressure pump through a column packed with a finely divided solid material. As the sample travels through that column, its individual components move at different rates depending on how strongly each one interacts with the packing. Components that interact weakly leave the column first; components that interact strongly are held back and leave later. A detector at the end of the column records each component as it exits, producing a plot of signal against time.

Two elements define any HPLC separation: the stationary phase (the solid packing inside the column) and the mobile phase (the liquid solvent that carries the sample). Separation happens because different molecules partition differently between those two phases. For peptide analysis, one particular configuration — reversed-phase HPLC — has become the dominant approach.

Why is reversed-phase HPLC used for peptides?

Reversed-phase high-performance liquid chromatography (RP-HPLC) separates molecules on the basis of hydrophobicity: the separation depends on the hydrophobic binding of each solute from the mobile phase to immobilized hydrophobic ligands attached to the stationary phase (source 2). In a typical peptide setup, the stationary phase is an n-alkylsilica sorbent — commonly a C18 (octadecyl) bonded silica — and the mobile phase is a mixture of water and an organic solvent such as acetonitrile, with a small amount of an ionic modifier like trifluoroacetic acid (source 2).

This matters for peptides because closely related molecules — the target peptide and its synthesis by-products, truncated sequences, and degradation products — often differ only slightly in structure, yet those small differences change hydrophobicity enough to separate them on an RP column. RP-HPLC has been used to determine homogeneity, identity, content, and purity for synthetic peptide reference standards in published characterization work (source 1), which is why it sits at the center of peptide quality control.

How does an HPLC run actually work?

Most peptide separations use a gradient rather than a fixed solvent mixture. The run begins with a mostly aqueous mobile phase, and the proportion of organic solvent (for example, acetonitrile containing 0.1 percent trifluoroacetic acid) is increased steadily over the course of the run. As the mobile phase becomes more organic, progressively more hydrophobic components are released from the column and pass to the detector. A representative analytical method might run a gradient from roughly 5 percent to 95 percent organic solvent over 20 to 60 minutes, on a 4.6 mm internal-diameter column packed with 5-micron particles, at a flow rate near 1 mL per minute.

The gradient is what gives RP-HPLC its resolving power: by sweeping through solvent strengths, a single run separates components that span a wide range of hydrophobicity. The exact gradient, column, and flow rate are part of the validated method, and a COA that reports a purity figure without naming the method behind it gives no way to judge how that figure was obtained.

How does an HPLC chromatogram show purity?

The output of an HPLC run is a chromatogram: a plot of detector signal on the vertical axis against time on the horizontal axis. Each component that leaves the column appears as a peak. Two features of each peak carry the information:

• Retention time — the time, in minutes, at which a component elutes. The target peptide elutes at a characteristic retention time that should be reproducible from run to run for a given method.
• Peak area — the area under a peak, which is proportional to the amount of that component. Purity is calculated by area normalization: the area of the main (target) peak divided by the total area of all peaks, expressed as a percentage.

So a reported purity of 99.2 percent means the main peak accounts for 99.2 percent of the total detected peak area, and everything else — each resolved impurity registering as its own smaller peak — makes up the remaining 0.8 percent. Read visually, a single sharp, symmetrical main peak on a flat baseline is the signature of a high-purity, well-resolved sample; a shoulder on the main peak, a cluster of small satellite peaks, or a drifting baseline points to impurities or to a method that is not cleanly separating them.

How are peptides detected during an HPLC run?

The most common detector is an ultraviolet (UV) absorbance detector. Peptides are typically monitored in the far-UV region around 214 nm, because the peptide bond itself absorbs strongly there. Molar extinction coefficients measured at 214 nm in the presence of acetonitrile were reported specifically to enable quantitative comparison of peptides eluting from reversed-phase HPLC (source 3), and the peptide bond's absorbance at that wavelength is what makes low-UV detection nearly universal for peptides. A wavelength of 220 nm is also widely used for the same reason.

Detecting at 214 nm has a practical advantage over detecting at 280 nm, where only aromatic residues (tryptophan, tyrosine, phenylalanine) absorb: a peptide that lacks those residues would be nearly invisible at 280 nm but is still readily detected at 214 nm through its peptide bonds. The trade-off is that many other substances also absorb in the far UV, so the mobile phase and solvents must be chosen to keep background absorbance low. For confirming molecular identity, UV detection is frequently paired with mass spectrometry downstream of the column.

What do 95, 98, and 99 percent purity actually indicate?

Because HPLC purity is a normalized area percentage, the headline number translates directly into an impurity fraction. The table below shows how common thresholds map to the amount of non-target material a figure implies.

A single percentage is not the whole story, though. Regulatory frameworks look past the headline figure at the individual impurities behind it: FDA guidance for certain highly purified synthetic peptide drug products states that any impurity present above 0.10 percent of the peptide should be individually identified, and that a new specified impurity above 0.5 percent generally must be qualified (source 4). In other words, two samples can both read 98 percent while differing in how well-characterized their remaining 2 percent is. Steadfast Research Group publishes the measured purity for each batch and documents the supporting HPLC and mass-spectrometry data batch by batch.

How does HPLC purity relate to a Certificate of Analysis?

A Certificate of Analysis (COA) is the document that carries the HPLC result off the instrument and onto the record for a specific batch. The purity line on a COA is the main-peak area percentage from the RP-HPLC run described above, and a complete COA attaches the chromatogram itself so the figure can be checked rather than merely asserted. Peptide quality control rests on a battery of complementary methods — identity, purity, and content determined against a well-characterized reference standard — not on any single measurement (source 1).

HPLC answers "how much of this sample is the target versus impurities," but it does not, on its own, prove that the main peak is the correct molecule; that identity question is answered by mass spectrometry. The two methods are therefore reported side by side on a rigorous COA. Because purity and impurity profiles are properties of one manufacturing run, the HPLC data are only meaningful when the certificate is tied to the lot number on the vial in hand.